Abstract
Background
Elevated inflammatory markers have been found to correlate with higher risk for cardiac events in patients with acute myocardial infarction (AMI). It has been suggested that C‐reactive protein (CRP) may be involved in the initiation process of atrial fibrillation (AF). However, the role of CRP levels in the occurence of AF in patients with AMI has not been studied. This study investigated whether CRP is a risk factor for AF in patients with acute anterior MI.
Methods
We prospectively evaluated 92 consecutive patients (25 women and 67 men; aged 58 ± 11 y) with a first acute anterior wall MI. Blood samples were obtained at the time of admission to the hospital, and serum CRP levels were measured by an ultrasensitive immunonephelometry method. All patients were evaluated by echocardiography to measure the left ventricular (LV) diameter and functions. All patients were monitored continuously for the detection of AF in the coronary care unit.
Results
Atrial fibrillation occured in 19 (20%) of 92 patients. Univariate analysis showed that patients with AF had an advanced age (63 ± 9.9 versus 56.7 ± 11.7 y, p = 0.034), higher serum CRP level (2.95 ± 2.5 versus 1.71 ± 2.12 mg/dL, p = 0.034), larger LV end‐systolic volume (74 ± 15 versus 63 ± 19, mL p = 0.02), higher LV ejection fraction (31.1 ± 6.2 versus 38.4 ± 10%, p = 0.001), and larger left atrial (LA) diameter (37.1 ± 4.2 versus 34.7 ± 3.3 mm, p = 0.01). In multivariate analysis, only age (odds ratio [OR]: 1.05, 95% confidence interval [CI]: 1–1.11, p = 0.036) and CRP levels (OR: 1.27, 95% CI: 1–1.59, p = 0.039) were independent predictors of AF.
Conclusion
These results suggest that CRP may be a risk factor for AF in patients with acute anterior wall MI. Copyright © 2008 Wiley Periodicals, Inc.
Keywords: myocardial infarction, arrhythmia
Full Text
The Full Text of this article is available as a PDF (150.6 KB).
References
- 1. Goldberg RJ, Seeley D, Becker RC, Brady P, Chen ZY, et al.: Impact of atrial fibrillation on the in‐hospital and long‐term survival of patients with acute myocardial infarction: a community‐wide perspective. Am Heart J 1990; 119(5): 996–1001. [DOI] [PubMed] [Google Scholar]
- 2. Pritchett EL: Management of atrial fibrillation. N Engl J Med 1992; 326(19): 1264–1271. [DOI] [PubMed] [Google Scholar]
- 3. Behar S, Zahavi Z, Goldbourt U, Reicher‐Reiss H, for The SPRINT Study Group: Long‐term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction. Eur Heart J 1992; 13(1): 45–50. [DOI] [PubMed] [Google Scholar]
- 4. Tanne D, Reicher‐Reiss H, Boyko V, Behar S, for The SPRINT Study Group: Stroke risk after anterior wall acute myocardial infarction. Am J Cardiol 1995; 76(11): 825–826. [DOI] [PubMed] [Google Scholar]
- 5. Hod H, Lew AS, Keltai M, Cercek B, Geft IL, et al.: Early atrial fibrillation during evolving myocardial infarction: a consequence of impaired left atrial perfusion. Circulation 1987; 75(1): 146–150. [DOI] [PubMed] [Google Scholar]
- 6. Crenshaw BS, Ward SR, Granger CB, Stebbins AL, Topol EJ, et al.: Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO‐I experience. Global utilization of streptokinase and TPA for occluded coronary arteries. J Am Coll Cardiol 1997; 30(2): 406–413. [DOI] [PubMed] [Google Scholar]
- 7. Eldar M, Canetti M, Rotstein Z, Boyko V, Gottlieb S, et al.: Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era. SPRINT and Thrombolytic Survey Groups. Circulation 1998; 97(10): 965–970. [DOI] [PubMed] [Google Scholar]
- 8. Pedersen OD, Bagger H, Kober L, Torp‐Pedersen C: The occurrence and prognostic significance of atrial fibrillation/‐flutter following acute myocardial infarction. TRACE Study group. TRAndolapril Cardiac Evalution. Eur Heart J 1999; 20(10): 748–754. [DOI] [PubMed] [Google Scholar]
- 9. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, et al.: C‐reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001; 104: 2886–2891. [DOI] [PubMed] [Google Scholar]
- 10. Aviles RJ, Martin DO, Apperson‐Hansen C, Houghtaling PL, Rautaharju P, et al.: Inflammation as a risk factor for atrial fibrillation. Circulation 2003; 108: 3006–3010. [DOI] [PubMed] [Google Scholar]
- 11. Libby P: Molecular basis of acute coronary syndromes. Circulation 1995; 91: 2844–2850. [DOI] [PubMed] [Google Scholar]
- 12. Rifai N, Tracy RP, Ridker PM: Clinical efficacy of an automated high‐sensitivity C‐reactive protein assay. Clin Chem 1999; 45: 2136–2141. [PubMed] [Google Scholar]
- 13. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, et al.: Recommendations for quantitation of the left ventricle by two‐dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two‐Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358–67. [DOI] [PubMed] [Google Scholar]
- 14. Cohen GI, Pietrolungo JF, Thomas JD, Klein AL: A practical guide to assessment of ventricular diastolic function using Doppler echocardiography. J Am Coll Cardiol 1996; 27(7): 1753–1760. [DOI] [PubMed] [Google Scholar]
- 15. Horowitz MS, Schultz CS, Stinson EB, Harrison DC, Popp RL: Sensitivity and specificity of echocardiographic diagnosis of pericardial effusion. Circulation 1974; 50: 239–47. [DOI] [PubMed] [Google Scholar]
- 16. Sanchez PL, Pabon P, Morinigo JL, Ledesma C, Martin F, et al.: Do baseline C‐reactive protein levels predict the new‐onset of atrial fibrillation in patients with acute coronary syndrome? Eur Heart J 2003; 24: 509A. [Google Scholar]
- 17. Nagahama Y, Sugiura T, Takehana K, Hatada K, Inada M, et al.: The role of infarction‐associated pericarditis on the occurrence of atrial fibrillation. Eur Heart J 1998; 19(2): 287–292. [DOI] [PubMed] [Google Scholar]
- 18. James TN: Myocardial infarction and atrial arrythmias. Circulation 1961; 24: 761–776. [DOI] [PubMed] [Google Scholar]
- 19. Flaker GC, Fletcher KA, Rothbart RM, Halperin JL, Hart RG, for Stroke Prevention in Atrial Fibrillation (SPAF) Investigators: Clinical and echocardiographic features of intermittent atrial fibrillation that predict recurrent atrial fibrillation. Am J Cardiol 1995; 76(5): 355–358. [DOI] [PubMed] [Google Scholar]
- 20. Celik S, Erdol C, Baykan M, Kaplan S, Kasap H, et al.: Relation between paroxysmal atrial fibrillation and left ventricular diastolic function in patients with acute myocardial infarction. Am J Cardiol 2001; 88(2): 160–162. [DOI] [PubMed] [Google Scholar]
- 21. Pietila KO, Harmoinen AP, Jokiniitty J, Pasternack AI: Serum C‐reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 mo of follow‐up in patients under thrombolytic treatment. Eur Heart J 1996; 17(9): 1345–1349. [DOI] [PubMed] [Google Scholar]
- 22. Toss H, Lindahl B, Siegbahn A, Wallentin L: Prognostic influence of increased fibrinogen and C‐reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. Circulation 1997; 96(12): 4204–4210. [DOI] [PubMed] [Google Scholar]
- 23. Takahashi T, Anzai T, Yoshikawa T, Maekawa Y, Asakura Y, et al.: Serum C‐reactive protein elevation in left ventricular remodeling after acute myocardial infarction–role of neurohormones and cytokines. Int J Cardiol 2003; 88(2–3): 257–265. [DOI] [PubMed] [Google Scholar]
- 24. Celik S, Baykan M, Erdol C, Kilinç K, Orem A, et al.: C‐Reactive protein as a risk factor for left ventricular thrombus in patients with acute myocardial infarction. Clin Cardiol 2001; 24(9): 615–619. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Anzai T, Yoshikawa T, Shiraki H, Asakura Y, Akaishi M, et al.: C‐reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q‐wave acute myocardial infarction. Circulation 1997; 96(3): 778–784. [DOI] [PubMed] [Google Scholar]
- 26. Engelmann MD, Svendsen JH: Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 2005; 26(20): 2083–2092. [DOI] [PubMed] [Google Scholar]
- 27. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, et al.: Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997; 96: 1180–1184. [DOI] [PubMed] [Google Scholar]
- 28. Gabay C, Kushner I: Acute‐phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448–454. [DOI] [PubMed] [Google Scholar]
- 29. Nattel S: New ideas about atrial fibrillation 50 y on. Nature 2002; 415: 219–226. [DOI] [PubMed] [Google Scholar]
- 30. Dernellis J, Panaretou M: Effects of C‐reactive protein and the third and fourth components of complement (C3 and C4) on incidence of atrial fibrillation. Am J Cardiol 2006; 97(2): 245–248. [DOI] [PubMed] [Google Scholar]
- 31. Griselli M, Herbert J, Hutchinson WL, Taylor KM, Sohail M, et al.: C‐reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med 1999; 190(12): 1733–1740. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Lagrand WK, Niessen HW, Wolbink GJ, Jaspars LH, Visser CA, et al.: C‐reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation 1997; 95(1): 97–103. [DOI] [PubMed] [Google Scholar]
- 33. Veselka J, Prochazkova S, Duchonova R, Bolomova I, Urbanova T, et al.: Relationship of C‐reactive protein to presence and severity of coronary atherosclerosis in patients with stable angina pectoris or a pathological exercise test. Coron Artery Dis 2002; 13(3): 151–154. [DOI] [PubMed] [Google Scholar]